Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: A pilot study

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 93-98

  Stein, Richard S ^a   Greer, John P ^b   Flexner, John M ^b   Goodman, Stacey ^b   Wolff, Steven N ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Acute non lymphocytic leukemia; Consolidation; Daunorubicin; Etoposide; High dose ara C; Mitoxantrone

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE; NARCOTIC ANALGESIC AGENT; OFLOXACIN; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; ATAXIA; BACTEREMIA; BLOOD TOXICITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOXICITY; FEMALE; FEVER; HUMAN; HUMAN CELL; ILEUS; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; LIVER TOXICITY; MALE; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; SEPTICEMIA; STOMATITIS; THROMBOCYTE TRANSFUSION;

EID: 0029823286     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054806     Document Type: Article

References (24)

1. Wolff, S. N., Marion, J., Stein, R. S. et al. (1985) High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute non-lymphocytic leukemia in first remission: A pilot study. Blood, 65, 1407-1411.
2. Wolff, S. N , Herzig, R. H., Phillips, G. L. et al. (1987) High-dose cytosine arabinoside and daunorubicin as brief consolidation therapy for acute non-lymphocytic leukemia in first remission: An update. Semin. Oncol., 14, 12-17 (suppl 2).
3. Wolff, S. N., Herzig, R. H., Fay, J. W et al. (1989) High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J. Clin. Oncol., 7, 1260-1267.
4. Preisler, H. D., Raza, A., Early, A. et al. (1987) Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. J. Clin. Oncol., 5, 722-730.
5. Tricot, G., Boogaerts, M. A., Vlietinck, R. et al. (1987) The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia. Br. J. Haematol., 66, 37-44.
6. Harousseau, J. L., Milpied, N., Briere, J et al. (1991) Double intenisve consolidation chemotherapy in adult acute leukemia. J. Clin. Oncol. 9, 1432-1437.
7. Cassileth, P. A., Lynch, E., Hines, J. D. et al (1992) Varying intensity of postremission therapy in acute myeloid leukemia. Blood, 79, 1924-1930.
8. Schiller, G., Gajewski, J., Territo, M. et al. (1992) Long term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood, 80, 2977-2982
9. Mayer, R. J., Davis, R. B., Schiffer, C. A. et al. (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N. Engl. J. Med., 331, 896-903.
10. Bloomfield, C. D., Lawrence, D., Arthur, D. C. et al. (1994) Curative impact of intensification with high-dose cytarabine in acute myeloid leukemia varies by cytogenetic group. Blood, 84, Suppl 1: 111a (abstract).
11. Goodman, S., Greer, J. P., Stein, R. S. et al. (1994) Extended VP16 administration for the treatment of acute leukemia Phase I/II studies (abstract). Proc. Am. Soc. Clin. Oncol., 13, 311.
12. Hainsworth, J. D., Johnson, D. H., Frazier, S. R. et al. (1989) Chronic daily administration of oral etoposide - a phase I trial. J. Clin. Oncol., 7, 396-401.
13. Johnson, D. H , Greco, F. A., Strupp, J. et al. (1990) Prolonged administration of oral etoposide in patients with relapsed or refractory small cell lung cancer: a phase II trial. J. Clin. Oncol., 8, 1613-1617.
14. Bennett, J M., Catovsky, D., Daniel, M. T. et al. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British cooperative Group. Ann. Intern. Med., 103, 620-625.
15. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
16. Peto, R., Pike, M. C., Armitage, P. et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br. J. Cancer, 35, 1-39.
17. Oken, M. M., Creech, R. H., Tormey, D. C. et al. (1982) Toxicity and response criterion of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 5, 649-652.
18. List, A. F., Spier, C., Greer, J. et al. (1993) Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J. Clin. Oncol., 11, 1652-1660.
19. Appelbaum, F. R., Fisher, L. D. and Thomas, E. D. (1988) Chemotherapy v bone marrow transplantation for adults with acute nonlymphocytic leukemia: A 5-year follow-up. Blood, 72, 179-184.
20. Champlin, R. E., Ho, W. G., Gale. R. P. et al. Treatment of acute myelogenous leukemia. A prospectively controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann. Intern. Med., 102, 285-291.
21. Clift, R. A., Buckner, C. D., Appelbaum, F. R. et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J. Clin. Oncol., 10, 1723-1729.
22. Brown, R.A , Wolff, S.N., Fay, J W. et al. (1995) High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse. A study of the North American Bone Marrow Transplant Group. Blood, 85, 1391-1395.
23. Yeager, A. M., Kaizer, H., Santos, G. W. et al. (1986) Autologous bone marrow transplantation in patients wish acute non-lymphoblastic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N. Engl. J. Med., 315, 141-147.
24. Meloni, G., Foa, R., Vignetti, M et al. (1994) Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood, 84, 2158-2163.